---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-086110"
form_type: "8-K"
ticker: null
cik: "0001834645"
company_name: "Peak Bio, Inc."
filed_at: "2024-07-24T23:59:59+00:00"
generated_at: "2026-05-31T17:05:51.727934+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Three Peak Bio directors resign; board reduced to three members

## Summary
- David Rosenberg, Michael Friedman, and Stephen LaMond resigned from Peak Bio's Board on July 19, 2024, effective immediately.
- Resignations for personal reasons; no disagreements with Company operations, policies, or practices.
- Board size reduced from six to three members following the departures.
- Stephen LaMond remains Interim CEO despite resigning as a director.

## SEC filing metadata
- accession: 0000950170-24-086110
- form_type: 8-K
- cik: 0001834645
- company_name: Peak Bio, Inc.
- filed_at: 2024-07-24T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1834645/000095017024086110/0000950170-24-086110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1834645/000095017024086110/pkbo-20240719.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-086110
- JSON: https://secwatch.observer/filing/0000950170-24-086110.json
- Plain text: https://secwatch.observer/filing/0000950170-24-086110.txt

## Key facts
- Executive change
  David Rosenberg resigned as Director at Peak Bio, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 19, 2024, David Rosenberg, Michael Friedman and Stephen LaMond, notified the Company of their resignations from the Company’s Board of Directors (the “Board”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1834645/000095017024086110/0000950170-24-086110-index.htm
- Executive change
  Michael Friedman resigned as Director at Peak Bio, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 19, 2024, David Rosenberg, Michael Friedman and Stephen LaMond, notified the Company of their resignations from the Company’s Board of Directors (the “Board”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1834645/000095017024086110/0000950170-24-086110-index.htm
- Executive change
  Stephen LaMond resigned as Director at Peak Bio, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 19, 2024, David Rosenberg, Michael Friedman and Stephen LaMond, notified the Company of their resignations from the Company’s Board of Directors (the “Board”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1834645/000095017024086110/0000950170-24-086110-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.